Palisade Bio
PALI
6 hedge funds and large institutions have $360K invested in Palisade Bio in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
44% less capital invested
Capital invested by funds: $644K → $360K (-$284K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$108K |
| 2 |
Bank of New York Mellon
New York
|
+$47.6K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$4.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$255K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $246K | +$108K | +25 | +43% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $76K | -$255K | -59 | -69% |
|
|
3
Bank of New York Mellon
New York
| $31K | +$47.6K | +11 | New |
|
4
UBS Group
Zurich,
Switzerland
| $3K | – | – | – |
|
5
BlackRock
New York
| $2K | – | – | – |
|
|
6
Victory Capital Management
San Antonio,
Texas
| $2K | +$4.32K | +1 | New |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$3K | -1 | Closed |
|
PALI Hedge Fund Activity: Q1 2020 in Review
6 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2020, worth a combined $360K — down 44% from $644K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PALI positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $108K. The largest seller was Sabby Management, cutting an estimated $255K.
- 6 institutional investors held Palisade Bio (PALI) as of Q1 2020, up from 5 in Q4 2019.
- Funds reported $360K of Palisade Bio stock for Q1 2020, down 44% quarter-over-quarter.
- 2 funds opened new Palisade Bio positions in Q1 2020 and 1 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q1 2020 was Renaissance Technologies, an estimated $108K added.
- The largest Palisade Bio seller in Q1 2020 was Sabby Management, an estimated $255K sold.
Based on aggregated 13F filings for Q1 2020.